HER2 Amplification Has no Prognostic Value in Sporadic and Hereditary Ovarian Tumours

Whereas HER2 amplification is a well-known phenomenon in breast tumours, its frequency and clinical importance in ovarian cancer have not been established. The aim of the study was to compare the frequency of HER2 amplification in hereditary (BRCA-positive) and sporadic (BRCA-negative) ovarian tumou...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Brożek, Izabela, Kardaś, Iwona, Ochman, Karolina, Dębniak, Jarosław, Stukan, Maciej, Ratajska, Magdalena, Morzuch, Lucyna, Emerich, Janusz, Limon, Janusz
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2006
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3401919/
https://ncbi.nlm.nih.gov/pubmed/20223002
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1897-4287-4-1-39
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires